RNS Number : 9330V

ConvaTec Group PLC

16 December 2021

ConvaTec Group PLC

Non-Executive Director Appointment

Reading, United Kingdom - 16(th) December 2021

ConvaTec Group PLC ("ConvaTec" or "the Company") is pleased to announce the appointment of Kimberly ("Kim") Lody as a Non-Executive Director of the Company with effect from 1 February 2022. Kim will join ConvaTec's Nomination and Remuneration committees on the same date.

Since 2019, Kim has been the President and Chief Executive O ffice r of Sonida Senior Living Corporation, one of the USA's largest owner-operators of senior housing communities. Kim has an extensive background in international, multi-cultural environments with more than 25 years of healthcare experience including alternate site healthcare services, durable medical equipment and medical devices.

From 2011-2019, Kim served firstly as President of Resound and then as SVP and President of GN Hearing, both of which are medical device divisions of the GN Group. From 2009 - 2011, Kim was Vice President of Marketing and then President of Chronic Care for the U.S. subsidiary of Coloplast. From 2004-2009, Kim was an independent consultant to the healthcare sector. Her earlier career included serving as COO of Senior Home Care; CMO of Gentiva Health Services; and VP of Managed Care Programs for Apria Healthcare.

Kim holds a bachelor's degree in Business Administration from Hiram College in Ohio and an MBA with a concentration in finance from Wake Forest University, North Carolina.

John McAdam, Chairman of ConvaTec, commented:

"I am delighted to welcome Kim to our Board. She has deep healthcare knowledge, an impressive track record and brings to the Board very relevant international, commercial and operational experience. We look forward to Kim's contribution to our Board discussions."

This announcement is made in accordance with Listing Rule 9.6.11R (1). No other information is required to be disclosed in accordance with Listing Rule 9.6.13.


Analysts and Investors

Kate Postans, Vice President, Investor Relations +44(0)7826 447 807



Buchanan: Chris Lane +44(0)207 466 5000

ConvaTec Group PLC's LEI code is 213800LS272L4FIDOH92

About ConvaTec Group PLC

ConvaTec is a global medical products and technologies company focused on therapies for the management of chronic conditions, with leading market positions in advanced wound care, ostomy care, continence and critical care, and infusion care. Our vision, which encompasses our purpose, is: Pioneering trusted medical solutions to improve the lives we touch. Our products provide a range of clinical and economic benefits including infection prevention, protection of at-risk skin, improved patient outcomes and reduced total cost of care. To learn more about ConvaTec, please visit www.convatecgroup.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.



(END) Dow Jones Newswires

December 16, 2021 08:59 ET (13:59 GMT)

Grafico Azioni Convatec (LSE:CTEC)
Da Apr 2022 a Mag 2022 Clicca qui per i Grafici di Convatec
Grafico Azioni Convatec (LSE:CTEC)
Da Mag 2021 a Mag 2022 Clicca qui per i Grafici di Convatec